About
- Name
- Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)
- Index tracked
- Hang Seng Innovative Drug Index PR HKD
- Type
- Equity
- Expense ratio
- --
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 1.4632 (08/24/2026)
- Issued units
- 1.97B (06/30/2026)
- Listing date
- Dec 16, 2024
- Sponsor
- Huatai-PineBridge Fund Mgmt Co., Ltd
- Custodian
- Citibank N.A.
ETF Documents
Last updatedType
03/31/2026Annual Report
09/02/2025Semi Annual Report
01/10/2026Prospectus
07/21/2026Quarterly Report